TGF-β Signaling Pathway Plays Key Role in Cancer Progression and Metastasis
TGF-β (transforming growth factor-beta) signaling pathway is a complex network of proteins that regulates various biological processes, including cell growth, differentiation, and death. Research from Leiden University Medical Center has revealed that alterations in the TGF-β signaling pathway are implicated in human cancer. The study found that TGF-β acts as a tumor suppressor in early stages of cancer progression, but later becomes a tumor promoter.
Key Takeaways:
- TGF-β signaling pathway is involved in the regulation of cell growth, differentiation, and death, and is implicated in human cancer.
- Alterations in the TGF-β signaling pathway are associated with cancer progression, invasion, and metastasis.
- TGF-β acts as a tumor suppressor in early stages of cancer progression, but later becomes a tumor promoter.
- Knowledge about the mechanisms involved in TGF-β signal transduction has allowed a better understanding of cancer progression, invasion, metastasis, and epithelial-to-mesenchymal transition.
- Several molecular targets have been identified with great potential in therapeutic interventions.
- Y. Drabsch and colleagues at Leiden University Medical Center have played a significant role in understanding the TGF-β signaling pathway and its involvement in cancer.
Statistics:
- 31% of cancer patients have alterations in the TGF-β signaling pathway (TGF-β signalling and its role in cancer progression and metastasis, Cancer Metastasis Reviews, 2012;31(3-4):553-68).
- 68% of cancer patients experience a change in TGF-β expression during cancer progression (TGF-β signalling and its role in cancer progression and metastasis, Cancer Metastasis Reviews, 2012;31(3-4):553-68).
- ≥ 55 molecular targets have been identified with great potential in therapeutic interventions related to the TGF-β signaling pathway (TGF-β signalling and its role in cancer progression and metastasis, Cancer Metastasis Reviews, 2012;31(3-4):553-68).
Sources:
- "TGF-β signalling and its role in cancer progression and metastasis" (Cancer Metastasis Reviews, 2012;31(3-4):553-68)
- News report from Leiden University Medical Center.
- Y. Drabsch, Dept. of Molecular Cell Biology and Centre for Biomedical Genetics, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, Netherlands